Related Experiment Video
Updated: Feb 23, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Acceptability and Results of Dementia Screening Among Older Adults in the United States
Amanda Harrawood1, Nicole R Fowler1, Anthony J Perkins1
1Department of Medicine, Indiana University, Center for Aging Research, Indianapolis, IN 46202. United States.
Objectives:
To measure older adults acceptability of dementia screening and assess screening test results of a racially diverse sample of older primary care patients in the United States.
Design:
Cross-sectional study of primary care patients aged 65 and older.
Setting:
Urban and suburban primary care clinics in Indianapolis, Indiana, in 2008 to 2009.
Participants:
Nine hundred fifty-four primary care patients without a documented diagnosis of dementia.
Measurements:
Community Screening Instrument for Dementia, the Mini-Mental State Examination, and the Telephone Instrument for Cognitive Screening.
Results:
Of the 954 study participants who consented to participate, 748 agreed to be screened for dementia and 206 refused screening. The overall response rate was 78.4%. The positive screen rate of the sample who agreed to screening was 10.2%. After adjusting for demographic differences the following characteristics were still associated with increased likelihood of screening positive for dementia: age, male sex, and lower education. Patients who believed that they had more memory problems than other people of their age were also more likely to screen positive for dementia.
Conclusion:
Age and perceived problems with memory are associated with screening positive for dementia in primary care.
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Cognitive Development During Adulthood
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

